Physician profile
Madison Dover
NPI 1376325944
$373.56
in general payments reported to CMS, 2019-2025
10 companies · $161 in 2025
The $161 reported for 2025 was less than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $213 · 2025: $161.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $374.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $373.56 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organon LLC | $112.86 | 2024-2025 | Nexplanon |
| Mayne Pharma Commercial LLC | $58.93 | 2024-2025 | |
| Exeltis, USA INC. | $51.24 | 2024-2025 | Slynd |
| Hologic Sales and Service, LLC | $31.58 | 2024 | Thinprep 2000 Processor, Aptima |
| Astellas Pharma US INC | $28.73 | 2024 | Veozah |
| Evofem Biosciences, INC. | $21.77 | 2025 | Phexxi, Solosec, Phexx |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $20.65 | 2025 | Caplyta |
| Convatec INC. | $17.77 | 2024 | |
| Dexcom, INC. | $15.89 | 2024 | Dexcom G6 Transmitter |
| Sumitomo Pharma America, INC. | $14.14 | 2025 | Myfembree |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Madison Dover listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.